Overview

A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

Status:
Recruiting
Trial end date:
2028-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Amlodipine
Losartan